Glioblastoma stem cells resistant to temozolomide-induced autophagy

Chinese Medical Journal

Volumn 122, Issue 11, 2009, Pages 1255-1259

  Fu, Jun ^a,b   Liu, Zhi Gang ^a,b   Liu, Xiao Mei ^a,b   Chen, Fu Rong ^a,b   Shi, Hong Liu ^a,b   Pang, Jesse Chung Sean ^c   Ng, Ho Keung ^c   Chen, Zhong Ping ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chemoresistance; Glioblastoma; Neoplastic stem cells; Temozolomide

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BECLIN 1; CASPASE 3; CD133 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; MEMBRANE PROTEIN; PROTEIN ATG5; PROTEIN LC3 II; PROTEIN P17; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; AUTOPHAGY; CANCER INHIBITION; CANCER RESISTANCE; CANCER STEM CELL; CELL ISOLATION; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EXPOSURE; ENZYME ACTIVATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MOLECULAR DYNAMICS; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR RESISTANCE; WESTERN BLOTTING;

ANTIGENS, CD; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CASPASE 3; CELLS, CULTURED; DACARBAZINE; DRUG RESISTANCE, NEOPLASM; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; PEPTIDES;

EID: 68249157942     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.11.004     Document Type: Article

References (22)

1. Salgaller ML, Liau LM. Current status of clinical trials for glioblastoma. Rev Recent Clin Trials 2006; 1: 265-281.
2. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; Epub ahead of print.
3. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumor initiating cells. Nature 2004; 432: 396-401.
4. Ziegler DS, Wright RD, Kesari S, Lemieux ME, Tran MA, Jain M, et al. Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins. J Clin Invest 2008; 118: 3109-3122.
5. Kang MK, Kang SK. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev 2007; 16: 837-847.
6. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5: 67.
7. Lefranc F, Facchini V, Kiss R. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 2007; 12: 1395-1403.
8. Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 2004; 11: 448-457.
9. He LF, Guan KP, Yan Z, Ye HY, Xu KX, Ren L, et al. Enhanced sensitivity to mitomycin C by abating heat shock protein 70 expression in human bladder cancer cell line of BIU-87. Chin Med J 2005; 118: 1965-1972.
10. Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, et al. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006; 13: 1238-1241.
11. Daido S, Yamamoto A, Fujiwara K, Sawaya R, Kondo S, Kondo Y. Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res 2005; 65: 4368-4375.
12. Iwamaru A, Kondo Y, Iwado E, Aoki H, Fujiwara K, Yokoyama T, et al. Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells. Oncogene 2007; 26: 1840-1851.
13. Meijer AJ. Amino acid regulation of autophagosome formation. Methods Mol Biol 2008; 445: 89-109.
14. Chen Y, McMillan-Ward E, Kong J, Israels SJ, Gibson SB. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ 2008; 15: 171-182.
15. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 2007; 26: 1749-1760.
16. Xie Z, Klionsky DJ. Autophagosome formation: core machinery and adaptations. Nat Cell Biol 2007; 9: 1102-1109.
17. Codogno P, Meijer AJ. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 2005; 12 Suppl 2: s1509-s1518.
18. Levine B, Sinha S, Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 2008; 4: 600-606.
19. Minniti G, De Sanctis V, Muni R, Filippone F, Bozzao A, Valeriani M, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol 2008; 88: 97-103.
20. Kanzawa T, Bedwell J, Kondo Y, Kondo S, Germano IM. Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide. J Neurosurg 2003; 99: 1047-1052.
21. Zeng X, Kinsella TJ. A novel role for DNA mismatch repair and the autophagic processing of chemotherapy drugs in human tumor cells. Autophagy 2007; 3: 368-370.
22. Jiang H, Gomez-Manzano C, Aoki H, Alonso MM, Kondo S, McCormick F, et al. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst 2007; 99: 1410-1414.